User-friendliness of a Portable Driving Simulator for Parkinson's, MS, and Stroke
This study is testing two driving simulators: a new, low-cost Portable Driving Simulator (PDS) and a larger, more expensive High Fidelity Fixed-Base Simulator. Researchers want to see how easy the Portable Driving Simulator is to use and if it causes simulator sickness in people with Parkinson's disease (PD), multiple sclerosis (MS), or who have had a stroke. They also want to compare if the Portable Driving Simulator can help improve driving skills as effectively as the High Fidelity Fixed-Base Simulator. You may be able to join if you are 25-75 years old, have a valid driver's license, and have been diagnosed with stroke, PD, or MS. The study will measure how easy the simulators are to use, how much simulator sickness occurs, and your driving performance. This study is currently recruiting 30 participants.
- Study design
- This is an interventional study with 30 planned participants. It compares a Low-Fidelity PDS device with a High Fidelity Fixed-Base Simulator device.
- What's involved
- You would participate in 5 visits over an average of one week. During these visits, your user-friendliness, simulator sickness, and driving performance will be assessed.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your user-friendliness will be assessed at the end of visits 2, 3, and 4. Simulator sickness will be assessed during visits 1, 2, 3, 4, and 5. Driving performance will be assessed during visits 1 and 5.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
User-friendliness of a Portable Driving Simulator
At a glance
Conditions
NCT03969927
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Abiodun Akinwuntan
Kansas City, Kansasno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Abiodun Akinwuntan, PhD, MPH MBA · PRINCIPAL_INVESTIGATOR · University of Kansas School of Health Professions
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- User-FriendlinessAssessed at the End of visit 2, visit 3, and visit 4. These visits will take place over an average of one week.
User-Friendliness will be assessed using a User-Friendliness Survey which is a Likert scale. \[1-5 scale with 1 representing the lowest degree of user-friendliness and 5 representing the highest degree of user-friendliness\]
- Simulator SicknessAssessed during visit 1, visit 2, visit 3, visit 4, and visit 5. These visits will take place over an average of one week.
Simulator Sickness and symptoms of Simulator Sickness will be assessed using questionnaire adapted from the 1993 Kennedy et al Simulator Sickness Questionnaire. \[This will be reported from a 0-228.14 scale with 0 representing the lowest possible degree of Simulator Sickness and 228.14 indicating the greatest possible degree of Simulator Sickness\]
- Driving PerformanceAssessed during visit 1, and visit 5. These visits will take place over an average of one week.
Driving Performance will be assessment by a Driving rehabilitation specialist before and after each participant undergoes training. The participants will be tested on the high-fidelity driving simulator and the driving simulator provide objective measurements of lane position maintenance, adherence to speed limits, reaction to traffic lights, and overall reaction time.